Thursday, May 28, 2015 9:12:13 PM
READ BELOW AND MAKE A PURCHASE ON THERE FIRST ITEM SO YOU CAN HOLD AND SEE THE TRUE VALU OF LIQUID METAL..
LONG LQMT....100,000+ SHARES AND BUYING ANOTHER 100,000 SOON...
READ BELOW.....
Hi Christopher,
Thank you very much for your order. I have reserved Hybrid Knife number 66 for you, the lowest available number. A PayPal invoice will follow shortly.
If you would like a different higher number, please send me the numbers you are interested in, and I will see what is available and update your invoice accordingly.
We have pre-sold just over 100 Hybrid Knives. All unreserved Hybrid knives will be sent to the BLADE SHOW, with the exception of the collector's edition, which will be finished later in June.
Please feel free to contact me if you have any questions.
Best Regards,
Juli
juli.adams@miltner-adams.com
__________________________________________________________________
Hi Christopher,
Thank you for your payment.
Best Regards,
Juli
juli.adams@miltner-adams.com
_________________________________________________________________
Hi Christopher,
Market Release: The Hybrid Knife™ will debut at the 2015 BLADE Show in Atlanta, GA , June 5-7, and will retail for $260.00 USD.
Shipping: The reserved numbered Hybrid Knives will ship immediately following the BLADE Show. Shipping cost will *not* be charged until the knives are ready to ship.
I will contact you as soon as your knife is packed and ready. I will not be at our booth at the show, so I can have all the pre-orders ready to ship as soon as possible.
Thank you.
Best Regards,
Juli
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM